1. Home
  2. DCTH vs OBT Comparison

DCTH vs OBT Comparison

Compare DCTH & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • OBT
  • Stock Information
  • Founded
  • DCTH 1988
  • OBT 1892
  • Country
  • DCTH United States
  • OBT United States
  • Employees
  • DCTH N/A
  • OBT N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • OBT Major Banks
  • Sector
  • DCTH Health Care
  • OBT Finance
  • Exchange
  • DCTH Nasdaq
  • OBT Nasdaq
  • Market Cap
  • DCTH 388.3M
  • OBT 368.1M
  • IPO Year
  • DCTH N/A
  • OBT N/A
  • Fundamental
  • Price
  • DCTH $9.83
  • OBT $24.45
  • Analyst Decision
  • DCTH Strong Buy
  • OBT Buy
  • Analyst Count
  • DCTH 4
  • OBT 1
  • Target Price
  • DCTH $24.25
  • OBT $29.00
  • AVG Volume (30 Days)
  • DCTH 1.1M
  • OBT 23.1K
  • Earning Date
  • DCTH 11-04-2025
  • OBT 10-29-2025
  • Dividend Yield
  • DCTH N/A
  • OBT 2.19%
  • EPS Growth
  • DCTH N/A
  • OBT 18.38
  • EPS
  • DCTH 0.06
  • OBT 3.03
  • Revenue
  • DCTH $70,240,000.00
  • OBT $115,418,000.00
  • Revenue This Year
  • DCTH $146.50
  • OBT $18.34
  • Revenue Next Year
  • DCTH $37.19
  • OBT $6.14
  • P/E Ratio
  • DCTH $175.70
  • OBT $8.08
  • Revenue Growth
  • DCTH 491.35
  • OBT 17.75
  • 52 Week Low
  • DCTH $8.87
  • OBT $20.97
  • 52 Week High
  • DCTH $18.23
  • OBT $33.06
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 40.06
  • OBT 48.55
  • Support Level
  • DCTH $9.15
  • OBT $23.25
  • Resistance Level
  • DCTH $12.70
  • OBT $24.79
  • Average True Range (ATR)
  • DCTH 0.73
  • OBT 0.83
  • MACD
  • DCTH -0.17
  • OBT 0.02
  • Stochastic Oscillator
  • DCTH 19.16
  • OBT 66.03

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

Share on Social Networks: